Novel hiv-specific synthetic oligonucleotides and methods of...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2300352

Disclosed are synthetic oligonucleotides having a nucleotide sequence specifically complementary to nucleotides 324 to 345 of a conserved gag region of the HIV-1 genome, the oligonucleotide consisting of 21 nucleotides which are linked via phosphorothioate internucleotide linkages. Also disclosed are methods for inhibiting and treating HIV-1 and HIV-2 infection.

L'invention concerne des oligonucléotides synthétiques présentant une séquence nucléotidique spécifiquement complémentaire des nucléotides 324 à 345 de la région gag conservée du génome du VIH-1, l'oligonucléotide se composant de 21 nucléotides lesquels sont liés par des liaisons internucléotidiques phosphorothioate. L'invention concerne également des méthodes d'inhibition et de traitement d'infections à VIH-1 et VIH-2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel hiv-specific synthetic oligonucleotides and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel hiv-specific synthetic oligonucleotides and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel hiv-specific synthetic oligonucleotides and methods of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1732623

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.